|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/40 | (2006.01) |
| C12N 9/64 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 3/06 | (2006.01) |
| (11) | Number of the document | 3156422 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16200305.7 |
| Date of filing the European patent application | 2009-12-15 | |
| (97) | Date of publication of the European application | 2017-04-19 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
| (46) | Date of publication of the claims translation | 2021-11-25 |
| (30) | Number | Date | Country code |
| 122482 P | 2008-12-15 | US | |
| 210566 P | 2009-03-18 | US | |
| 168753 P | 2009-04-13 | US | |
| 218136 P | 2009-06-18 | US | |
| 249135 P | 2009-10-06 | US | |
| 261776 P | 2009-11-17 | US |
| (72) |
SLEEMAN, Mark W. , AU
MARTIN, Joel H. , US
HUANG, Tammy, T. , US
MACDONALD, Douglas , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Didelio giminingumo žmogaus antikūnai prieš PCSK9 |
| HIGH AFFINITY HUMAN ANTIBODIES TO PCSK9 |
| Payment date | Validity (years) | Amount | |
| 2025-10-23 | 17 | 347.00 EUR |
| 2026-12-15 |